Rare diseases
Investigational molecules
Locations
382 conditions with trials, the busiest first
846 trials across Europe, recruiting first
Study of TX000045 for Pulmonary Hypertension in Heart Failure Patients with Preserved Ejection Fraction
AustriaStudy on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome
AustriaStudy on the Effects of Mosliciguat for Patients with Pulmonary Hypertension Linked to Interstitial Lung Disease
BelgiumLong-term safety and effectiveness study of pozelimab and cemdisiran combination treatment in adults with paroxysmal nocturnal hemoglobinuria (PNH)
GreeceStudy on the Safety and Effectiveness of Pozelimab and Cemdisiran for Adults with Paroxysmal Nocturnal Hemoglobinuria Not Recently Treated with Complement Inhibitors
GreeceStudy on Istaroxime for Patients with Cardiogenic Shock Stage C
CzechiaStudy on the Safety of Ticagrelor and Aspirin in Patients with Acute Coronary Syndrome
PolandStudy of Sotatercept for People with Pulmonary Arterial Hypertension
CzechiaStudy Comparing Dabigatran with Ticagrelor or Clopidogrel for Patients with Acute Coronary Syndrome Undergoing PCI
The NetherlandsStudy on FX06 for Improving Acute Respiratory Distress Syndrome in Patients
FranceStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
AustriaStudy on the Safety and Effectiveness of TAK-755 (Apadamtase Alfa) for Patients with Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
AustriaThe therapies tested most often in Vascular disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
